Atlas Trials

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Clinical trial NCT06864936 · RECRUITING

Trial details

NCT number
NCT06864936
Sponsor
University of Maryland, Baltimore
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiple Sclerosis (MS) - Relapsing-remitting
Start date
2026-05-01
Primary completion
2027-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.